Dihalokynurenic Acid Ester Synthesis with Low-Temperature Flow Cyclization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The commercial production of 4-ureido-5,7-dihalo-quinoline-2-carboxylate compounds is hindered by the harsh conditions required for preparing intermediates, such as high temperatures and the expense of solvents, as well as difficulties in purifying and recovering solvents in existing synthesis methods.

Innovation Solution

A method involving the use of P2O5 in methanesulfonic acid (Eaton's reagent) at lower temperatures in a continuous flow reactor to cyclize dialkyl 1-(3,5-dihalophenylamino)ethylene-1,2-dicarboxylate compounds, allowing for the preparation of alkyl 5,7-dihalo-1,4-dihydro-4-oxoquinoline-2-carboxylate esters, followed by a series of reactions to produce diphenylureido-dihalokynurenic acid esters, which are analgesic agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If high temperature heating (250°C) is used to cyclize the Michael adduct to form the quinoline ester intermediate, then the cyclization reaction proceeds to completion, but the energy consumption increases and the reaction conditions become harsh and difficult to control

Engineering Contradiction:
Improvecyclization reaction completionVSAvoidenergy consumption
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent changes the temperature parameter from 250°C to a lower range (60-100°C) by introducing Eaton's reagent (P2O5 in methanesulfonic acid) as a catalyst system. This parameter change enables the cyclization reaction to proceed efficiently at milder temperatures, reducing energy consumption while maintaining reliable reaction completion.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Eaton's reagent acts as an intermediary catalyst that facilitates the cyclization reaction at lower temperatures. The reagent mediates between the Michael adduct and the quinoline ester product, enabling the transformation to occur under milder conditions without requiring extreme heating.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Temperature

If diphenyl ether solvent is used for high temperature cyclization, then the reaction can proceed at 250°C, but the solvent expense increases and solvent recovery becomes difficult

Engineering Contradiction:
Improvereaction temperatureVSAvoidsolvent cost and recovery difficulty
Core Design Contradiction:
TemperatureVSLoss of substance

Solution Approach 1:

The patent changes the solvent system from diphenyl ether to Eaton's reagent (P2O5 in methanesulfonic acid), which allows the reaction to proceed at lower temperatures (60-100°C). This parameter change eliminates the need for expensive high-temperature solvents and simplifies product isolation, as the reaction can be performed in a catalytic amount of solvent that is easily removed.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses Eaton's reagent as a disposable catalytic system where the solvent (methanesulfonic acid) is used in relatively small amounts and can be easily removed after reaction. The P2O5 is used as a solid catalyst that can be filtered off, eliminating the need for expensive solvent recovery processes required for diphenyl ether.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Device complexity

If conventional batch processing is used for the cyclization reaction, then the reaction can be performed with simple equipment, but the production efficiency is low and scalability is limited

Engineering Contradiction:
Improveequipment simplicityVSAvoidproduction efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent transitions from batch processing to continuous flow processing for the cyclization reaction. In the flow reactor, the Michael adduct solution and Eaton's reagent continuously flow through a heated coil reactor, enabling uninterrupted production. This continuous operation significantly increases production efficiency while maintaining equipment simplicity, as the flow reactor consists of basic components (pump, heated coil, collector) that are easy to operate and scale.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables safer, more efficient, and scalable synthesis of diphenylureido-dihalokynurenic acid esters, achieving high yields and purities without the need for high temperatures and solvent recovery, suitable for treating chronic pain and alcohol dependence.

Implementation Method 1

A method involving the use of P2O5 in methanesulfonic acid (Eaton's reagent) at lower temperatures in a continuous flow reactor to cyclize dialkyl 1-(3,5-dihalophenylamino)ethylene-1,2-dicarboxylate compounds

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS12503441B2Process for preparing diphenylureido-dihalokynurenic acids and tosylate addition salts thereof
Publication Date: 2025.12.23 LOHOCLA RESEARCH CORP
  • US12503441B2 patent drawing
  • US12503441B2 patent drawing
  • US12503441B2 patent drawing

AI summary

A method of preparing 5,7-dihalo-1,4-dihydro-4-oxoquinoline-2-carboxylic acid tosylate addition salts is provided, which involves direct conversion of esters of Formula V as described herein to acids of Formula VIII as described herein. Tosylate addition salts of Formula IX as described herein are then prepared from the acids of Formula VIII.